Kaposi's sarcoma-associated herpesvirus (KSHV) K8.1 late promoter consists of a minimal 24-bp sequence, with a TATA-like, 12-bp promoter core, AATATTAAAGGG, and is active on a reporter only in butyrate-induced KSHV-infected cells. The activity of the K8.1 promoter can be enhanced (>15-fold) by the KSHV left-end lytic origin of DNA replication (oriLyt-L) sequence while providing inefficient replication of plasmid DNA and is inhibited by viral DNA replication inhibitors, suggesting that activation of the K8.1 promoter on the reporter is involved in KSHV lytic DNA replication largely by trans.
Kaposi's sarcoma-associated herpesvirus (KSHV) closely resembles human Epstein-Barr virus (EBV) (4) . Like other gammaherpesviruses, KSHV infection displays two viral life cycles. Latent KSHV infection in KS tissues and B-cell lines features the highly restricted expression of only five genes (7, 33) . The lytic KSHV life cycle is characterized by production of progeny virus from infected cells and can be induced by tetradecanoyl phorbol acetate and n-butyrate in PEL-derived B cells with latent KSHV infection (21, 22, 24) . KSHV K8.1 is a viral late gene that encodes a viral envelope glycoprotein at a late stage of virus infection. The sensitivity of K8.1 expression to a viral DNA polymerase inhibitor, phosphonoacetic acid (PAA) (17, 29) , suggests that K8.1 is a true late gene (␥2) whose expression, like that of other herpesvirus ␥2 genes (11, 19, 28, 30, 31) , depends on viral DNA replication.
Transcription of the K8.1 late gene in butyrate-induced KSHV-infected JSC-1 cells starts at nucleotide (nt) 75901, 14 nt upstream of the first AUG codon at nt 75915 in the virus genome (29) . As a result, a putative K8.1 promoter was hypothesized to exist upstream of the start site for transcription initiation.
To study the putative K8.1 promoter, we had to overcome some technical limitations. The putative predicted K8.1 promoter overlaps two KSHV genes: ORF50 and K8 (32) . ORF50 encodes a transactivator, RTA (replication and transcription activator), responsible for initiating all KSHV early gene expression. K8 is a gene encoding a leucine zipper protein involved in viral DNA replication (16) . Mutation in this region in the context of the virus genome will affect expression of the ORF50 and K8 genes and viral DNA replication. Thus, it is not feasible to study the K8.1 late promoter in its native context. As an alternative, we established a transient-transfection assay to study the putative K8.1 promoter, using various sizes of PCR-amplified fragments immediately upstream of nt 75915, but not overlapping the K8 promoter region (17) . All fragments were cloned into the KpnI and XhoI sites upstream of the firefly luciferase open reading frame (ORF) in a pGL3 luciferase reporter vector lacking eukaryotic origins of replication (Promega, Madison, Wis.). The activity of each promoter-firefly luciferase reporter construct was examined from cell lysate supernatant by a dual luciferase assay (Promega) 48 h after transfection of 3 g of the construct, together with 2 g of Renilla luciferase reporter (RL-TS) (13) and 14 g of sheared salmon sperm DNA into B lymphocytes (5 ϫ 10 6 cells) by electroporation at 250 V and 950 F with an Electro Cell Manipulator (BTX ECM630; BTX, San Diego, Calif.). KSHV K8.1 promoter activity is induced in KSHV-infected cells only by trans. Plasmid pST7 (Fig. 1C ) was first examined for its promoter activity in 293 cells and showed no activity with or without chemical stimulation and ORF50 and/or K8 cotransfection (data not shown). This experiment excluded the possibility of an immediate-early or early promoter-like activity residing in this construct. Next, we examined the promoter activity of the pST7 plasmid in several B-cell lines, including Raji (EBV-infected but replication-defective) cells (6), SUDHL6 cells (a B-cell line with no virus infection) (18), JSC-1 (KSHV-infected, EBV-infected cells), and BCBL-1 (KSHV-infected, non-EBV-infected) cells. The pST7 plasmid conferred no or very little promoter activity in either butyratestimulated or unstimulated Raji cells and SUDHL6 cells but conferred strong promoter activity in both butyrate-stimulated JSC-1 ( Fig. 1A ) and BCBL-1 cells ( Fig. 1B ) that was comparable to that of the simian virus 40 (SV40) early promoter (pGL3-SV40 vector in Fig. 1A and B ), suggesting that a specific KSHV, but not EBV, protein(s) must be involved in trans activation. This regulation has to do with viral lytic but not latent protein(s), since uninduced JSC-1 and BCBL-1 cells did not support much K8.1 promoter activity.
Mapping of the K8.1 promoter to a functional promoter core conferring full promoter activity in JSC-1 cells. To identify the transcription factor-binding sites that might regulate the activity of the K8.1 promoter in viral lytic induction, a series of successive deletions in the 1-kb K8.1 promoter was made from its 5Ј end progressively to its 3Ј end (Fig. 1C ). The deletion mutants did not show much difference in their promoter activity in butyrate-stimulated JSC-1 cells. A 58-bp region proximal to the 3Ј end (pST18) contributed a similar amount of promoter activity, as did the 1-kb K8.1 promoter (pST7) (Fig. 1C) , indicating that the 58-bp region fully functions as a K8.1 promoter. In addition, a series of plasmids having various 3Ј extensions of the 1-kb K8.1 promoter to include additional sequences up to 73 bp downstream of nt 75915 showed only a minimal effect on K8.1 promoter activity (data not shown). Together, these results demonstrate that a functional K8.1 promoter is not subject to regulation by a cis-acting transcription factor-binding site either upstream or downstream of the 58-bp K8.1 promoter.
FIG. 1. A putative K8.1 late promoter can be activated by butyrate only in KSHV-infected cell lines.
A promoter-luciferase (luc) reporter vector, pST7, containing a 1-kb fragment immediately upstream of the K8.1 ORF, was electroporated into four different B-cell lines: Raji, SUDHL6, JSC-1 (A), and BCBL-1 (B). A series of successive deletions in the 1-kb fragment, beginning at the 5Ј end and progressing to the 3Ј end, were also examined, and their promoter activities in JSC-1 cells were determined (C). The plasmid name is shown to the left of the schematic representation, and the size (in base pairs) of the insert is shown in parenthesis. Downstream of each insert is a firefly luc gene. The numbers above and below the lines are nucleotide positions of the first and last nucleotides of the insert in the virus genome (GenBank accession number U75698) (25) . The K8.1 transcription start site is indicated by the arrow. Cells were collected 48 h after transfection and incubation with or without butyrate (3 mM), and the supernatant of the cell lysate was examined for dual luciferase activities. Relative promoter activity was calculated by dividing the light unit readings obtained from a tested promoter-firefly luciferase reporter construct by the light unit readings obtained from the Renilla luciferase reporter. The pGL3-basic and pGL3-SV40 vectors were used as negative and positive controls, respectively. Panel A shows the results from one of three experiments, and panels B and C show the results from one of two experiments.
To better define which sequences within the 58-bp region specify K8.1 promoter activity, another series of deletion or point mutations were made in the 58-bp promoter. Examination of the promoter activity of each mutant in butyrate-stimulated JSC-1 cells ( Fig. 2A ) demonstrated that the K8.1 promoter activity resides in the 24 bp at its 5Ј half (pST41) and is orientation sensitive (pST36), suggesting its independence on an initiator (Inr) at the transcription start site or downstream activation sequences (DAS) as described in other viral late promoters (8, 10, 14, 15, 23) . The sequence of the 5Ј half of the 58-bp promoter, CCGGCAGCAATATTAAAGGGAC CC, features a central TATA-like motif, TATT, flanked by several A's. To characterize the function of this putative TATA-like motif, we chose a 3Ј-truncated 45-bp promoter (pST34) with promoter activity similar to that of the 58-bp promoter (pST18) in butyrate-induced JSC-1 cells for introduction of point mutations. The conversion of TT to CG in the TATT motif (pST37) effectively disrupted its activation by butyrate in JSC-1 cells.
Having identified that a 24-bp sequence in the 5Ј half of the 58-bp K8.1 promoter is responsible for the promoter activity and that the TATT motif within the 5Ј half functions as a TATA box, we wished to determine whether the sequences flanking this TATT box are important for the sufficient and active function of the TATA-like box. A randomized 3-bp linker-scanning mutation was introduced progressively from 5Ј to 3Ј into the 24-bp K8.1 promoter, and each mutant was analyzed in butyrate-stimulated JSC-1 cells. As shown in Fig.  2B , the sequences flanking the TATT box were demonstrated to play important roles in trans activation of the 24-bp promoter by butyrate. Interestingly, the wild-type (wt) but not mutant 24-bp promoter by itself was capable of binding the TATA-binding protein (TBP) in our gel shift assays (Fig. 2C) . Thus, a K8.1 late promoter core was identified; it consists of a 12-bp sequence (AATATTAAAGGG), including the TATT box at position Ϫ34 relative to the K8.1 transcription start site and its flanking sequences immediately upstream and downstream.
The size of the crucial 12-bp K8.1 promoter core is similar to that of the herpes simplex virus type 1 gC late promoter core (12) . Both are embedded in GC-rich flanking sequences and contain signals essential for fully regulated activation. However, the gC promoter core has a sequence, GGGTATAAAT TCCGG, which deviates from the consensus Goldberg-Hogness sequence (GGGTATAAATA) (2) by only 1 nt, whereas the defined K8.1 12-bp promoter core, like the SV40 11-bp late ). wt and mutant (MT) doublestranded DNA oligonucleotides, equivalent to the K8.1 promoter sequences in pST41 and pST46, respectively, were labeled with 32 P and used for the protein-DNA complex formation that was resolved on a 4% native polyacrylamide gel (9).
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promoter core (GGTACCTAACC) (2), deviate much further from the Goldberg-Hogness sequence. A TATT box, deviating by 1 nt at the fourth position from the sequence of the classical TATA box for TBP binding to recruit RNA polymerase II, appears to be common in many viral late promoters, including cytomegalovirus U L 94 (31) and U L 75 (20) , EBV BcLF1 (26), and KSHV AP (3). Sensitivity of trans-activated K8.1 late promoter activity to PAA and GCV in butyrate-induced JSC-1 cells. To examine whether the K8.1 promoter identified in our transient-transfection assay could represent an authentic late promoter in responding to viral DNA replication inhibitors, two versions of the K8.1 promoter, a 1-kb promoter in pST7 and a 24-bp promoter in pST41, were further analyzed in butyrate-induced JSC-1 cells in the presence or absence of PAA or ganciclovir (GCV). The activities of both promoters were sensitive to PAA, but not GCV (Fig. 3A and B) , with PAA inhibiting promoter activity by up to 60%, indicating an association with viral lytic DNA replication. Although PAA did not inhibit the transient K8.1 promoter activity completely, this was expected, since neither of the vectors containing the K8.1 promoter was able to replicate, due to lack of eukaryotic origins of DNA replication. This was further supported by data showing that the transient promoter activity in butyrate-induced JSC-1 cells was insensitive to a DNA chain elongation terminator, GCV (5) . However, transcription of the late gene K8.1 in JSC-1 cells was sensitive to both PAA (96% inhibition) and GCV (87% inhibition) ( Fig. 3C ), suggesting that our transient promoter assay reveals only a partial recapitulation of activation of the authentic late promoter in the context of the virus genome.
A viral oriLyt functions in cis, acting to enhance activation by trans of the K8.1 late promoter. To overcome the replication incompetence of the plasmids described above, a KSHV leftend lytic origin of DNA replication (oriLyt-L) (1) was inserted downstream of the luciferase ORF driven by the K8.1 promoter. Five original K8.1 promoter plasmids (pST41, pST7, pST26, pST36, and pST46) were chosen for insertion of the KSHV oriLyt-L sequence (Fig. 4A) , and their promoter activities were examined in butyrate-induced JSC-1 cells. As shown in Fig. 4B , once the oriLyt sequence was inserted, the promoter activities of plasmids with a wt K8.1 promoter either in a long (1-kb) or short (24-bp) version (pST52, pST53, pST60, pST54, and pST55) were greatly enhanced (more than 15-fold) with butyrate, independent of oriLyt orientation. The same sets of plasmids with a wt K8.1 promoter plus the viral oriLyt were also tested in butyrate-induced BCBL-1 cells and 293 cells. The plasmids reproducibly showed the same results only in butyrate-induced BCBL-1 cells, not in 293 cells (data not shown). In contrast, the K8.1 promoter with mutations in its TATT box or in an antisense orientation did not have enhanced activity in the presence of oriLyt (pST61, pST57, pST58, and pST59 in Fig. 4B ). This was expected, since the original plasmids (pST46 and pST36) lacking the viral oriLyt sequence had no promoter activity ( Fig. 2A and B) .
The much higher level of K8.1 promoter activity in butyrateinduced JSC-1 cells with the viral oriLyt-containing plasmid p53 (Fig. 4A ) was sensitive to PAA and GCV, with an inhibition up to 97% by PAA and 80% by GCV (Fig. 4C) . Thus, the 24-bp promoter on this plasmid appeared to fully imitate the activation of an authentic K8.1 promoter in responding to viral lytic DNA replication and DNA replication inhibitors in the context of the virus genome. The finding that GCV, a DNA chain elongation terminator, inhibited the oriLyt-enhanced K8.1 promoter activity provides further evidence that KSHV (Fig.  1) . Panels A and B show the data from one of three experiments. Abbreviations: No treat., no treatment; Bu., butyrate. (C) Total cell RNA extracted at 48 h from JSC-1 cells treated with (ϩ) or without (Ϫ) butyrate, PAA, and GCV was analyzed for K8.1 mRNA with an RNase protection assay by using an antisense RNA probe C (29) . A human cyclophilin antisense probe (Ambion, Austin, Tex.) was also used as an internal control for normalization of sampling. lytic DNA replication, including DNA chain elongation, is itself directly engaged in activation of the late promoter on the reporter.
To determine whether the viral oriLyt-enhanced K8.1 promoter activity is attributable to plasmid replication, a transientreplication assay (1) was conducted in parallel with pST53. As shown in Fig. 4D , inserting KSHV oriLyt in pST53 conferred only a very low level of plasmid DNA replication in butyrateinduced JSC-1 cells, as evidenced by the presence of some DpnI-resistant DNA (lane 6) and its sensitivity to MboI digestion (lane 7) and to DNA replication inhibitors PAA and GCV (lanes 8 and 9) . These results indicate that maintenance of plasmid DNA replication or template (copy number) amplification is unlikely to play a major role in inducing a much (30) . The specific trans-acting factors important to K8.1 promoter activation in KSHV-infected cells appear to be independent of viral ORF50, since cotransfection with ORF50 did not promote much promoter activity of both replication-competent and -incompetent plasmids (data not shown). If ORF50 has any effect, it might be indirect. We speculate that this transacting factor(s) may be a component(s)-perhaps a viral early gene product(s)-of the viral lytic, but not latent, DNA replication (initiation and elongation) machinery, since uninduced JSC-1 cells did not support much K8.1 promoter activity. A similar observation in the EBV late promoters BcLF1 and BFRF3 supports such a trans relationship (27) . Although the underlying mechanisms that link the late promoter activation and KSHV lytic DNA replication remain unknown and the reporter assays in this study may not fully reflect regulation in the intact virus, the finding that KSHV K8.1 late promoter can be activated largely by trans in viral lytic DNA replication provides a new insight into regulation of KSHV late gene expression.
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